Latest Shareholder Approvals News

New World Resources Limited has entered a binding agreement for acquisition by Central Asia Metals Plc at a significant premium, valuing the company at approximately A$185 million. The transaction, unanimously recommended by New World’s board, is set to complete by September 2025, subject to shareholder and court approvals.

Bryah Resources has secured an option to acquire the Golden Pike high-grade gold project in New Brunswick, Canada, featuring a historical inferred resource of over 66,000 ounces of gold. The move positions Bryah to capitalize on strong gold prices with plans for extensive exploration and resource upgrade.

Talga Group has successfully raised A$10 million through a strategic share placement to advance its Vittangi Anode Project, supported by key institutional investors and board members.

Nimy Resources has raised $2.75 million through a share placement to fast-track exploration and resource definition at its promising Block 3 gallium discovery in Western Australia amid soaring global gallium prices.

Island Pharmaceuticals has raised $3.6 million through a strategic share placement to advance its lead antiviral drug ISLA-101’s clinical development and broaden its asset portfolio ahead of pivotal Phase 2a/b trial results.

First Au Limited has entered a binding term sheet to progressively acquire full ownership of the Nimba Gold Project in Liberia, backed by a planned A$1 million equity raise to fund exploration. The project’s proximity to a major West African gold mine and promising drill results position FAU for a strategic expansion into a stable, mining-friendly jurisdiction.

Oceana Lithium Limited has successfully raised $667,000 through a discounted share placement, attracting strong support from institutional and high-net-worth investors. The funds will accelerate exploration and development across its Australian and Brazilian lithium assets.

Gold Road Resources has secured a crucial regulatory green light as the Foreign Investment Review Board approves Gold Fields’ acquisition scheme. The deal now moves closer to shareholder and court approvals.

ASPI Isotopes Inc. has agreed to acquire Renergen Limited in an all-share deal, creating a vertically integrated global entity focused on critical materials for semiconductors, medical isotopes, and green energy. The transaction addresses Renergen’s liquidity challenges and positions the combined company for growth across multiple strategic sectors.

Macarthur Minerals has secured $250,000 through unsecured convertible notes to bolster its working capital and support ongoing operations amid challenging market conditions.

Chimeric Therapeutics has raised $6.6 million through a discounted two-tranche placement to accelerate its promising CAR-T and NK cell therapy clinical programs. The capital raise, strongly backed by institutional and professional investors, signals growing confidence in the company’s oncology pipeline.

Atomo Diagnostics Limited has announced a capital raising initiative comprising a Share Purchase Plan (SPP) and a Placement, aiming to raise up to $1 million through the SPP and additional funds via a Placement, subject to shareholder approval at a June 23 meeting.